ArticleCanada communicable disease report = Releve des maladies transmissibles au Canada2015
Travel-related chikungunya cases in Canada, 2014.
Article in Canada communicable disease report = Releve des maladies transmissibles au Canada, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.
- Prevalence of chronic comorbidities in chikungunya: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2018Pooled it
- Five Hot Topics in Tropical Medicine: 2025.Infectious disease reports · 2026Review
- The Invasive Mosquitoes of Canada: An Entomological, Medical, and Veterinary Review.The American journal of tropical medicine and hygiene · 2022Review
- Current and Projected Distributions ofEnvironmental health perspectives · 2020Article
- Could exotic mosquito-borne diseases emerge in Canada with climate change?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2019Article
- A reporting guide for Rapid Communications.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2017Article
- Assessment of the Probability of Autochthonous Transmission of Chikungunya Virus in Canada under Recent and Projected Climate Change.Environmental health perspectives · 2017Article
- Risk perceptions, attitudes, and knowledge of chikungunya among the public and health professionals: a systematic review.Tropical medicine and health · 2017Review
- Illness in Canadian travellers and migrants from Brazil: CanTravNet surveillance data, 2013-2016.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2016Article
- Spectrum of Viral Pathogens in Blood of Malaria-Free Ill Travelers Returning to Canada.Emerging infectious diseases · 2016Article
- First Imported Case of Chikungunya Virus Infection in a Travelling Canadian Returning from the Caribbean.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2016Article
- Is there a risk of chikungunya transmission in Canada?Canada communicable disease report = Releve des maladies transmissibles au Canada · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the spring of 2014, there has been a large increase in travel-related chikungunya cases diagnosed in Canada. As of December 9, 2014, 320 confirmed and 159 probable cases have been diagnosed in Canada, with the majority of provinces identifying at least one imported case. This surge in Canadian infections has been associated with the incursion of chikungunya virus into the Caribbean and the expansion of the virus in the Americas. Ongoing outbreaks in the Asia-Pacific region have also contributed to imported cases among Canadian travellers. Heightened awareness of chikungunya among clinicians is key to diagnosis. This highlights the need to ask for a travel history from anyone who presents with fever or recent onset of polyarthralgia, and to consider testing by provincial laboratories and the National Microbiology Laboratory for chikungunya virus and other diseases as indicated. Also essential is continued communication with travellers regarding the use of preventative measures to decrease the risk of exposure to mosquitoes when travelling to endemic areas.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.